J

Jaguar Health
D

JAGX

1.04000
USD
0.04
(4.27%)
Market Closed
Volume
2,638
EPS
0
Div Yield
0
P/E
0
Market Cap
9,610,880
Related Instruments
    A
    AKTX
    -0.45000
    (-10.66%)
    3.77000 USD
    B
    BNGO
    -0.05270
    (-8.23%)
    0.58760 USD
    N
    NAOV
    -0.01280
    (-1.74%)
    0.72490 USD
    N
    NVIV
    0
    (0%)
    0.000000 USD
    S
    SNDL
    -0.07000
    (-3.08%)
    2.20000 USD
    Z
    ZOM
    -0.00010
    (-0.07%)
    0.14950 USD
    More
News

Title: Jaguar Health Inc.

Sector: Healthcare
Industry: Biotechnology
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.